Women's Cancer News
Oct. 1, 2014

Adding cediranib to chemo improves progression-free survival for metastatic or recurrent cervical cancer, phase II trial shows
Medical News Today
For patients with cervical cancer that has recurred after treatment or has spread elsewhere in the body, adding the experimental drug cediranib to standard chemotherapy improves tumor shrinkage and adds a modest improvement in progression-free survival, researchers report at the ESMO 2014 Congress in Madrid. More

Practice Survey deadline extended to Oct. 13

Full and Candidate Members: The deadline has been extended to Oct. 13 to take SGO’s Practice Survey. If you missed the email with your personal link to the survey, please click here. Robust results may help you negotiate a higher salary. Those who complete the survey will receive the 2015 State of the Subspecialty report at no charge.More

BAM: A major cause of diarrhea in cancer patients
Clinical Oncology
Poor absorption of bile acid is the cause of chronic diarrhea in a large proportion of cancer patients, new research shows. The study of 506 patients with diarrhea and a variety of cancer types found that 43 percent had bile acid malabsorption (BAM), suggesting an opportunity to substantially improve quality of life in patients with this complication. The study provides the basis for a more focused approach to diarrhea in cancer patients, said Frank Phillips, MD, a trainee gastroenterologist at the Royal Marsden Hospital, in London, England, who presented the study at Digestive Disease Week 2014.More

Gelsolin plays role in destroying chemo-resistant ovarian cancer cells
Medical News Today
Gelsolin (GSN) is an important etiologic factor in chemoresistance in vitro, researchers reported recently in the Proceedings of the National Academy of Sciences. They also concluded that the application of C-terminal GSN may represent a new therapeutic strategy for chemoresistant gynecologic cancer. The in vitro findings were also validated with a clinical investigation that determines the relationship between GSN expression and cis-Diammine dichloroplatinium (II) sensitivity in human ovarian tumor.More

Ovarian cancer oncogene found in 'junk DNA'
Oncology Nurse Advisor
A research team mined junk DNA sequences to identify a non-protein-coding RNA whose expression is linked to ovarian cancer in a study published in Cancer Cell. The researchers built a DNA copy number profile for nearly 14,000 long noncoding RNAs, or lncRNAs across 12 cancer types, including ovarian and breast cancers that include the two major BRCA-related cancers. They found that the number of copies of lncRNA genes on a chromosome consistently changes in the 12 different cancer types. Also, lncRNA genes are widely expressed in cancer cells.More

Pertuzumab 'unprecedented' in extending lives
FOX News
A new breast cancer drug, pertuzumab, has shown "unprecedented" benefits in extending lives in a clinical trial and experts urged its widespread use for women with an aggressive form of the disease. Patients with a type of breast cancer known as HER2 positive, which makes up about a quarter of all breast cancers, who were given Perjeta on top of older medicine Herceptin and chemotherapy lived 15.7 months longer than those on Herceptin and chemotherapy alone.More

New technique could improve the outcome of breast cancer surgery
Medical Xpress
A new technique will help surgeons to detect where the margins of cancerous breast tumors are during surgery, reducing the need for secondary operations in breast cancer patients. Scientists have developed a highly accurate prototype technique which can produce a detailed 'molecular fingerprint' of breast tissues removed during surgery. This technique – which can produce detailed maps of the tissue - has the potential to improve the outcome for breast cancer surgery and to reduce unnecessary secondary operations, according to the study published in Physics in Medicine and Biology.More

New IBD research connects Crohn's disease with cervical neoplasia
Inflammatory Bowel Disease News Today
A recent study published in Clinical Gastroenterology and Hepatology reported a new link between Crohn’s disease (CD) and uterine cervix neoplastic lesions. The researchers commented: “Women with a diagnosis of CD had increased risk of cervical dysplasia and cancer despite similar screening intensity as in the general population. Patients with UC only had increased risk of dysplasia along with a slightly increased screening frequency compared to controls. Patients with IBD should be encouraged to follow the screening program for cervical neoplasia and clinicians should be aware of the slightly increased risk of HPV-related cervical lesions in IBD patients.”More

Fusion of CTLA-4 with HPV16 E7 and E6 enhanced potency of therapeutic HPV DNA vaccine
PLOS One
Using CTLA-4 with E7 and E6 can enhance cellular and humoral immune responses against HPV16, according to a study published Sept. 29 in PLOS One. This strategy may provide useful ideas for developing therapeutic HPV DNA vaccines. However, further studies are needed to optimize the strategy. More